In the second part, we are covering anti-obesity medications that are being tested to treat heart disease and how scientists and physicians are addressing health equity challenges around these drugs. Most recently, initial studies have shown that they can reduce the risk of cardiovascular disease by reducing overall body weight. In the international, multicenter trial, more than 17,000 patients who were 45 years or older, had cardiovascular disease, and were overweight or had diabetes.